The PROs and cons of crystalline lactulose for suspected covert HE among patients with cirrhosis and activity impairment: Are we using the right assessments?

MeSH terms

• Gastrointestinal Agents
• Hepatic Encephalopathy* / diagnosis
• Hepatic Encephalopathy* / drug therapy
• Hepatic Encephalopathy* / etiology
• Humans
• Lactulose* / therapeutic use
• Liver Cirrhosis / complications
• Liver Cirrhosis / diagnosis
• Liver Cirrhosis / drug therapy